Literature DB >> 8557138

Danazol versus a gonadotropin-releasing hormone agonist as preoperative preparation for hysteroscopic metroplasty.

L Fedele1, S Bianchi, L Gruft, G Bigatti, M Busacca.   

Abstract

OBJECTIVE: To compare the efficacy of danazol and a GnRH agonist as preoperative preparation for hysteroscopic metroplasty in women with septate uterus.
DESIGN: Prospective randomized clinical study.
SETTING: Tertiary care center. PATIENTS: Thirty patients with septate uterus.
INTERVENTIONS: The patients were randomized to treatment with danazol 600 mg/d for 2 to 4 weeks (n = 15) or with leuprolide acetate depot 3.75 mg for 2 months (n = 15) as preoperative therapy for hysteroscopic metroplasty. MAIN OUTCOME MEASURES: At the intervention the hysteroscopist evaluated difficulty in dilation of the cervical canal, presence of endometrial fragments, bleeding, difficulty in maneuvering the resectoscope, and operating time.
RESULTS: Both the treatments were well tolerated. Metroplasty was simpler overall in the danazol group and also faster in introducing the resectoscope through the cervical canal and maneuvering it in the uterine cavity were both easier. Bleeding was modest in both groups and the anatomic outcome of the operation was similar.
CONCLUSION: Short preoperative preparation with danazol results in favorable operating conditions at limited costs with minimal side effects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557138     DOI: 10.1016/s0015-0282(16)58049-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  1 in total

1.  Fertility and pregnancy outcomes following resectoscopic septum division with and without intrauterine balloon stenting: a randomized pilot study.

Authors:  Basim Fouad Abu Rafea; George Angelos Vilos; Ayman Mohamad Oraif; Stephen George Power; Jackie Hollet Cains; Angelos George Vilos
Journal:  Ann Saudi Med       Date:  2013 Jan-Feb       Impact factor: 1.526

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.